<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>58(1)</volume><submitter>Kim J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The treatment strategy for intestinal non-Hodgkin lymphoma (NHL) and the role of surgery warrant reevaluation.&lt;h4>Methods&lt;/h4>This study analyzed clinical data from a cohort of 12,047 patients diagnosed with intestinal NHL, extracted from the Korean National Health Insurance System database between 2002 and 2021.&lt;h4>Results&lt;/h4>Among these patients, 3,566 (29.6%) were categorized into the surgery group, while 8,481 (70.4%) were included in the nonsurgery group. Surgery was independently associated with both prolonged overall survival (OS) and a favorable prognosis in multivariate analysis (Hazard Ratio [HR] = 0.645, 95% Confidence Interval [CI] = 0.598-0.695, &lt;i>p&lt;/i> &lt;.001). The median OS was longer in patients who underwent lymph node dissection during surgery than in patients who did not undergo lymph node dissection (10-year OS with lymph node dissection 63.17% vs. surgery without lymph node dissection 54.78%, &lt;i>p&lt;/i> &lt; .001).&lt;h4>Conclusions&lt;/h4>To our knowledge, this is the first Korean population-based nationwide study to describe the clinical impact of surgery on the OS of patients with intestinal NHL. A prospective randomized study evaluating strategies to improve the survival of intestinal NHL patients is needed.</pubmed_abstract><journal>Annals of medicine</journal><pagination>2634447</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12934337</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The surgery for the patients with intestinal non‑Hodgkin lymphomas: a nationwide study.</pubmed_title><pmcid>PMC12934337</pmcid><pubmed_authors>Hwang SH</pubmed_authors><pubmed_authors>Choi JH</pubmed_authors><pubmed_authors>Kim J</pubmed_authors><pubmed_authors>Hur JY</pubmed_authors><pubmed_authors>Won YW</pubmed_authors><pubmed_authors>Lee JH</pubmed_authors></additional><is_claimable>false</is_claimable><name>The surgery for the patients with intestinal non‑Hodgkin lymphomas: a nationwide study.</name><description>&lt;h4>Background&lt;/h4>The treatment strategy for intestinal non-Hodgkin lymphoma (NHL) and the role of surgery warrant reevaluation.&lt;h4>Methods&lt;/h4>This study analyzed clinical data from a cohort of 12,047 patients diagnosed with intestinal NHL, extracted from the Korean National Health Insurance System database between 2002 and 2021.&lt;h4>Results&lt;/h4>Among these patients, 3,566 (29.6%) were categorized into the surgery group, while 8,481 (70.4%) were included in the nonsurgery group. Surgery was independently associated with both prolonged overall survival (OS) and a favorable prognosis in multivariate analysis (Hazard Ratio [HR] = 0.645, 95% Confidence Interval [CI] = 0.598-0.695, &lt;i>p&lt;/i> &lt;.001). The median OS was longer in patients who underwent lymph node dissection during surgery than in patients who did not undergo lymph node dissection (10-year OS with lymph node dissection 63.17% vs. surgery without lymph node dissection 54.78%, &lt;i>p&lt;/i> &lt; .001).&lt;h4>Conclusions&lt;/h4>To our knowledge, this is the first Korean population-based nationwide study to describe the clinical impact of surgery on the OS of patients with intestinal NHL. A prospective randomized study evaluating strategies to improve the survival of intestinal NHL patients is needed.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Dec</publication><modification>2026-07-10T03:26:20.384Z</modification><creation>2026-07-10T03:16:25.896Z</creation></dates><accession>S-EPMC12934337</accession><cross_references><pubmed>41732903</pubmed><doi>10.1080/07853890.2026.2634447</doi></cross_references></HashMap>